Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.transproceed.2020.09.006 http://scihub22266oqcxt.onion/10.1016/j.transproceed.2020.09.006 33127076!7491991!33127076     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33127076&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Transplant+Proc 2020 ; 52 (9): 2642-2653 Nephropedia Template TP {{tp|p=33127076|t=2020. Effects of Coronavirus Disease 2019 on Solid Organ Transplantation |pdf=|usr=}}{{33127076}} gab.com Text Effects of Coronavirus Disease 2019 on Solid Organ Transplantation JO: Transplant Proc http://www.kidney.de/pget.php?&tw=1&pmid=33127076 #FOAvip BACKGROUND: As the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged as a viral pandemic, data on the clinical characteristics and outcomes of patients with SARS-CoV-2 infection undergoing solid organ transplant are emerging. The objective of this systematic review was to assess currently published literature relating to the management, clinical course, and outcome of SARS-CoV-2 infection in liver, kidney, and heart solid organ transplant recipients. METHODS: We conducted a systematic review to assess currently published literature relating to the management, clinical course, and outcome of SARS-CoV-2 infection in liver, kidney, and heart solid organ transplant recipients. Articles published through June 2020 were searched in the MEDLINE, ClinicalTrials.gov, and PubMed databases. We identified 49 eligible studies comprising a total of 403 solid organ transplant recipients. RESULTS: Older age, male sex, and preexisting comorbidities, including hypertension and/or diabetes, were the most common prevailing characteristics among the solid organ transplant recipients. Clinical presentation ranged from mild to severe disease, including multiorgan failure and death. We found an overall mortality rate of 21%. CONCLUSION: Our analysis suggests no increase in overall mortality or worse outcome in solid organ transplant recipients receiving immunosuppressive therapy compared with mortality in the general surgical population with SARS-CoV-2. Our findings suggest that transplant surgery and its immunosuppressive effects should not be a deterrent to proper surgical care for patients in the SARS-CoV-2 era. Twit Text FOAVip Effects of Coronavirus Disease 2019 on Solid Organ Transplantation ????Transplant Proc http://www.kidney.de/pget.php?&tw=1&pmid=33127076 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33127076 #FOAvip English Wikipedia <ref>{{Cite pmid|33127076}}</ref> Effects of Coronavirus Disease 2019 on Solid Organ Transplantation #MMPMID33127076 Aziz H; Lashkari N; Yoon YC; Kim J; Sher LS; Genyk Y; Kwon YK Transplant Proc 2020[Nov]; 52 (9): 2642-2653 PMID33127076show ga BACKGROUND: As the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged as a viral pandemic, data on the clinical characteristics and outcomes of patients with SARS-CoV-2 infection undergoing solid organ transplant are emerging. The objective of this systematic review was to assess currently published literature relating to the management, clinical course, and outcome of SARS-CoV-2 infection in liver, kidney, and heart solid organ transplant recipients. METHODS: We conducted a systematic review to assess currently published literature relating to the management, clinical course, and outcome of SARS-CoV-2 infection in liver, kidney, and heart solid organ transplant recipients. Articles published through June 2020 were searched in the MEDLINE, ClinicalTrials.gov, and PubMed databases. We identified 49 eligible studies comprising a total of 403 solid organ transplant recipients. RESULTS: Older age, male sex, and preexisting comorbidities, including hypertension and/or diabetes, were the most common prevailing characteristics among the solid organ transplant recipients. Clinical presentation ranged from mild to severe disease, including multiorgan failure and death. We found an overall mortality rate of 21%. CONCLUSION: Our analysis suggests no increase in overall mortality or worse outcome in solid organ transplant recipients receiving immunosuppressive therapy compared with mortality in the general surgical population with SARS-CoV-2. Our findings suggest that transplant surgery and its immunosuppressive effects should not be a deterrent to proper surgical care for patients in the SARS-CoV-2 era. |*Immunocompromised Host[MESH] |*Transplant Recipients[MESH] |Aged[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Comorbidity[MESH] |Coronavirus Infections/*immunology/mortality[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Organ Transplantation[MESH] |Pandemics[MESH] |Pneumonia, Viral/*immunology/mortality[MESH]Effects of Coronavirus Disease 2019 on Solid Organ Transplantation (epmc).pdf DeepDyve Pubget Overpricing